Compugen (CGEN) announced leadership transitions to take effect in September 2025 following the Annual General Meeting. Anat Cohen-Dayag, currently President and CEO, will assume the newly created role of Executive Chair of the Board of Directors, subject to shareholder approval. Eran Ophir, currently Chief Scientific Officer, has been appointed President and CEO and will join the Board of Directors, subject to shareholder approval. Paul Sekhri will step down as Chair of the Board of Directors. Cohen-Dayag has led Compugen as President and CEO since 2010. In her new role as Executive Chair, Cohen-Dayag will focus on Compugen’s corporate strategy, strategic collaborations, and be involved in investor relations. Ophir has served in various managerial and executive roles at Compugen for nearly a decade.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.